Citalopram
- Product NDC
- 50090-5172
- 11-digit product format
- 500905172
- Labeler code
- 50090
- Product ID
- 50090-5172_3edc302b-9e97-403f-95fd-6c48d227de39
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Citalopram
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA077534
- Marketing category
- ANDA
- Marketing start
- 2016-07-22
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Citalopram
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CITALOPRAM HYDROBROMIDE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I1E9D14F36 |
| Rxcui | 200371 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-5172-0 | 2023-02-07 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
| 50090-5172-1 | 2023-02-07 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
| 50090-5172-2 | 2023-02-07 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
| 50090-5172-3 | 2023-02-07 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
| 50090-5172-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
| 50090-5172-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
| 50090-5172-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
| 50090-5172-3 | 2023-01-30 | C162847 | 48780-1 | f386c649-b002-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CITALOPRAM® safely and effectively. See full prescribing information for CITALOPRAM®. Citalopram Tablets, for oral use Initial U.S. Approval: 1998 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5172-0 | Citalopram | 30 in 1 BOTTLE | TABLET | 30 | | 7 |
| 50090-5172-1 | Citalopram | 60 in 1 BOTTLE | TABLET | 60 | | 7 |
| 50090-5172-2 | Citalopram | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
| 50090-5172-3 | Citalopram | 90 in 1 BOTTLE | TABLET | 90 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5172 | CITALOPRAM TABLET [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, Legacy NDC, 4 package rows | 20240501_c91684c7-fddb-4cf0-9711-b0484c8c7e8b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5172-0 | 50090517200 | 30 TABLET in 1 BOTTLE (50090-5172-0) | 30 tablet | 2020-09-25 | 0000-00-00 | No | No | Current |
| 50090-5172-1 | 50090517201 | 60 TABLET in 1 BOTTLE (50090-5172-1) | 60 tablet | 2020-09-25 | 0000-00-00 | No | No | Current |
| 50090-5172-2 | 50090517202 | 100 TABLET in 1 BOTTLE (50090-5172-2) | 100 tablet | 2020-09-25 | 0000-00-00 | No | No | Current |
| 50090-5172-3 | 50090517203 | 90 TABLET in 1 BOTTLE (50090-5172-3) | 90 tablet | 2020-09-25 | 0000-00-00 | No | No | Current |